150 related articles for article (PubMed ID: 32245107)
1. Development of a Cartilage Oligomeric Matrix Protein Neo-Epitope Assay for the Detection of Intra-Thecal Tendon Disease.
Smith R; Önnerfjord P; Holmgren K; di Grado S; Dudhia J
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245107
[TBL] [Abstract][Full Text] [Related]
2. Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis.
Skiöldebrand E; Ekman S; Mattsson Hultén L; Svala E; Björkman K; Lindahl A; Lundqvist A; Önnerfjord P; Sihlbom C; Rüetschi U
Equine Vet J; 2017 Sep; 49(5):662-667. PubMed ID: 28097685
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of tendon extracellular matrix reveals disease stage-specific fragmentation and differential cleavage of COMP (cartilage oligomeric matrix protein).
Dakin SG; Smith RK; Heinegård D; Önnerfjord P; Khabut A; Dudhia J
J Biol Chem; 2014 Feb; 289(8):4919-27. PubMed ID: 24398684
[TBL] [Abstract][Full Text] [Related]
4. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.
Lorenzo P; Aspberg A; Saxne T; Önnerfjord P
Osteoarthritis Cartilage; 2017 Sep; 25(9):1436-1442. PubMed ID: 28473207
[TBL] [Abstract][Full Text] [Related]
5. Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury.
Smith RK; Heinegård D
Equine Vet J; 2000 Jan; 32(1):52-8. PubMed ID: 10661386
[TBL] [Abstract][Full Text] [Related]
6. Effect of circadian rhythm, age, training and acute lameness on serum concentrations of cartilage oligomeric matrix protein (COMP) neo-epitope in horses.
Ekman S; Lindahl A; Rüetschi U; Jansson A; Björkman K; Abrahamsson-Aurell K; Björnsdóttir S; Löfgren M; Hultén LM; Skiöldebrand E
Equine Vet J; 2019 Sep; 51(5):674-680. PubMed ID: 30739342
[TBL] [Abstract][Full Text] [Related]
7. Novel cartilage oligomeric matrix protein (COMP) neoepitopes identified in synovial fluids from patients with joint diseases using affinity chromatography and mass spectrometry.
Åhrman E; Lorenzo P; Holmgren K; Grodzinsky AJ; Dahlberg LE; Saxne T; Heinegård D; Önnerfjord P
J Biol Chem; 2014 Jul; 289(30):20908-16. PubMed ID: 24917676
[TBL] [Abstract][Full Text] [Related]
8. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids.
Misumi K; Vilim V; Clegg PD; Thompson CC; Carter SD
Osteoarthritis Cartilage; 2001 Feb; 9(2):119-27. PubMed ID: 11237659
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids.
Vilim V; Lenz ME; Vytasek R; Masuda K; Pavelka K; Kuettner KE; Thonar EJ
Arch Biochem Biophys; 1997 May; 341(1):8-16. PubMed ID: 9143347
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease.
Arai K; Misumi K; Carter SD; Shinbara S; Fujiki M; Sakamoto H
Equine Vet J; 2005 Jan; 37(1):31-6. PubMed ID: 15651731
[TBL] [Abstract][Full Text] [Related]
11. Sandwich ELISA system for cartilage oligomeric matrix protein in equine synovial fluid and serum.
Yamanokuchi K; Tagami M; Nishimatsu E; Shimizu Y; Hirose Y; Komatsu K; Misumi K
Equine Vet J; 2009 Jan; 41(1):41-6. PubMed ID: 19301580
[TBL] [Abstract][Full Text] [Related]
12. Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in determining function-specific mechanical characteristics of locomotor tendons.
Smith RK; Gerard M; Dowling B; Dart AJ; Birch HL; Goodship AE
Equine Vet J Suppl; 2002 Sep; (34):241-4. PubMed ID: 12405694
[TBL] [Abstract][Full Text] [Related]
13. Increased cartilage oligomeric matrix protein concentrations in equine digital flexor tendon sheath synovial fluid predicts intrathecal tendon damage.
Smith MR; Wright IM; Minshall GJ; Dudhia J; Verheyen K; Heinegård D; Smith RK
Vet Surg; 2011 Jan; 40(1):54-8. PubMed ID: 21077920
[TBL] [Abstract][Full Text] [Related]
14. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
Skiöldebrand E; Lorenzo P; Zunino L; Rucklidge GJ; Sandgren B; Carlsten J; Ekman S
Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA.
Vilím V; Vobůrka Z; Vytásek R; Senolt L; Tchetverikov I; Kraus VB; Pavelka K
Clin Chim Acta; 2003 Feb; 328(1-2):59-69. PubMed ID: 12559599
[TBL] [Abstract][Full Text] [Related]
16. Cartilage oligomeric matrix protein forms protein complexes with synovial lubricin via non-covalent and covalent interactions.
Flowers SA; Kalamajski S; Ali L; Björkman LI; Raj JR; Aspberg A; Karlsson NG; Jin C
Osteoarthritis Cartilage; 2017 Sep; 25(9):1496-1504. PubMed ID: 28373131
[TBL] [Abstract][Full Text] [Related]
17. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population.
Taylor SE; Weaver MP; Pitsillides AA; Wheeler BT; Wheeler-Jones CP; Shaw DJ; Smith RK
Equine Vet J; 2006 Nov; 38(6):502-7. PubMed ID: 17124839
[TBL] [Abstract][Full Text] [Related]
18. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load.
Smith RK; Zunino L; Webbon PM; Heinegård D
Matrix Biol; 1997 Nov; 16(5):255-71. PubMed ID: 9501326
[TBL] [Abstract][Full Text] [Related]
19. COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis.
Sandstedt J; Vargmar K; Björkman K; Ruetschi U; Bergström G; Hultén LM; Skiöldebrand E
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1218-1228. PubMed ID: 33472398
[TBL] [Abstract][Full Text] [Related]
20. Serum level of cartilage oligomeric matrix protein (COMP) in equine osteoarthritis.
Misumi K; Vilim V; Hatazoe T; Murata T; Fujiki M; Oka T; Sakamoto H; Carter SD
Equine Vet J; 2002 Sep; 34(6):602-8. PubMed ID: 12358001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
